Rodec Pharma has got the Securities and Exchange Board of India’s (SEBI) approval to raise funds through initial public offering (IPO). The company’s maiden public offering will be entirely an offer-for-sale of 56.5 lakh shares by promoter Mukesh Kumar Gupta. Hence, the company will not receive any funds from the offer.
The company had filed its draft papers in January 2026. Shares of the company are proposed to be listed on the BSE and the NSE. In SEBI's parlance, obtaining observations is equivalent to securing approval to float a public offering.
Rodec Pharma, incorporated in 1997, is engaged in the manufacturing of animal feed supplements and marketing of veterinary pharmaceutical drugs and animal feed supplements to address healthcare and nutritional requirements of livestock animals under the for the animal healthcare sector.
